Log In Sign up
The largest database of trusted experimental protocols

Accula

Manufactured by Altona Diagnostics
Visit Supplier

The Accula is a compact, point-of-care diagnostic device designed for rapid molecular testing. It is capable of detecting the presence of specific genetic markers or sequences in biological samples.

Automatically generated - may contain errors

Lab products found in correlation

Neumodx, by Qiagen (2 mentions) Eplex respiratory pathogen panel 2, by Roche (2 mentions) Realstar sars cov 2 assays, by Altona Diagnostics (2 mentions) Xpert xpress sars cov 2 flu rsv, by Cepheid (2 mentions) Aptima, by Hologic (2 mentions)

2 protocols using accula

1

SARS-CoV-2 Screening and Diagnosis Protocols

Cited 3 times
Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 molecular testing for asymptomatic screening or diagnosis is performed at Johns Hopkins Diagnostic laboratory by either NeuMoDx (Qiagen) [10 (link), 11 (link)], cobas (Roche) [10 (link)], Aptima (Hologic), Xpert Xpress SARS-CoV-2/Flu/RSV (Cepheid) [12 ], ePlex respiratory pathogen panel 2 (Roche) [13 (link)], Accula [14 ], or RealStar SARS-CoV-2 assays (Altona diagnostics) [15 (link)]. Testing was performed in accordance with the manufacturer instructions and the Johns Hopkins laboratory’s validated protocols. Patients with greater than 1 positive SARS-CoV-2 test were identified, and were included if final and initial positive tests were >90 days apart. Samples were matched to our sequencing surveillance database for sequencing information.
Morris C.P., Eldesouki R.E., Fall A., Gaston D.C., Norton J.M., Gallagher N., Luo C.H., Abdullah O., Klein E.Y, & Mostafa H.H. (2022). Sequence Proven Reinfections with SARS-CoV-2 at a Large Academic Center. medRxiv.
+ Open protocol
+ Expand
2

SARS-CoV-2 Molecular Testing for Asymptomatic Screening

Cited 5 times
Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 molecular testing for asymptomatic screening or diagnosis was performed at Johns Hopkins Diagnostic Laboratory using NeuMoDx (Qiagen) (20 (link), 21 (link)), cobas (Roche) (20 (link)), Aptima (Hologic), Xpert Xpress SARS-CoV-2/Flu/RSV (Cepheid) (22 (link)), ePlex respiratory pathogen panel 2 (Roche) (23 (link)), Accula (24 (link)), or RealStar SARS-CoV-2 assays (altona Diagnostics) (25 (link)). Testing was performed in accordance with the manufacturers’ instructions and the Johns Hopkins laboratory’s validated protocols. Patients with greater than 1 positive SARS-CoV-2 test were identified and were included if final and initial positive tests were more than 90 days apart. Samples were matched to our sequencing surveillance database for sequencing information.
Morris C.P., Eldesouki R.E., Fall A., Gaston D.C., Norton J.M., Gallagher N.D., Luo C.H., Abdullah O., Klein E.Y, & Mostafa H.H. (2022). SARS-CoV-2 reinfections during the Delta and Omicron waves. JCI Insight, 7(20), e162007.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!